INTRODUCTION
Cytogenetic prenatal detection of Down's syndrome using mid-trimester amniocentesis was introduced in the South Western (S.W.) Region in the mid-1970s. The programme was based on maternal age because of the observation that increased maternal age was associated with increased risk of chromosomal abnormality (1) .
A study was undertaken to review the impact of this programme in the South West, and to relate these findings to national and international programmes. (13) . Many more amniocenteses could thus be needed with increased cost to the programme.
Methods
There are significant differences in the ranges of MSAFP for given risk prediction of Down's syndrome from various laboratories in the United States and Great Britain (14) and there is a lack of uniformity of the technical assays involved in measuring MSAFP levels (15 (20) .
First trimester detection of Down's syndrome by chorionic villous biopsy (21) and by maternal biochemical screening is also being investigated (22) . Up to 80% of trisomy 21 fetuses abort spontaneously in the first trimester (11) . The elderly mother has a much higher chance of carrying a trisomy 21 fetus in the first trimester, than at amniocentesis or at birth.
Objective counselling will require that the obstetrician inform the mother clearly on both the chances of abnormality at sampling and at the time of birth.
CONCLUSIONS
Prenatal screening based on increased maternal age has a theoretical reduction of live born Down's syndrome of 30%, 
